Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Yuan L, Li Y, Chen M, et al
Filingeri noted that this research study was designed to further examine changes in weight, body fat mass, and muscle mass in patients taking incretin medications. We found that, under close supervision and regular follow-up from an obesity medicine specialist, patients were able to lose fat mass with only a minimal decline in muscle mass. Alexandra Filingeri, DCN, RCN Filingeri pointed out that the results of this study cannot be generalized to patients receiving medication via telemedicine without routine body composition analysis, nor can they be generalized to in-person visits without utilizing body composition analysis
Body weight and food intake were subsequently monitored daily in the afternoon
Additional secondary outcomes included TSPO and tau PET, amyloid load and APOE4 status
The drug, called Foundayo, is the second GLP-1 weight-loss pill
It was as if Id spent my entire life running toward the next tasty morsel, compelled by a drumbeat of hunger and lured by the promise of a delicious reprieve while others strolled along, nibbling absentmindedly on the occasional nut
